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Changes in membrane sphingolipid 
composition modulate dynamics 
and adhesion of integrin 
nanoclusters
Christina Eich1,†, Carlo Manzo2, Sandra de Keijzer1, Gert-Jan Bakker3, Inge Reinieren-Beeren1, 
Maria F. García-Parajo2,4 & Alessandra Cambi1,*
Sphingolipids are essential constituents of the plasma membrane (PM) and play an important role in 
signal transduction by modulating clustering and dynamics of membrane receptors. Changes in lipid 
composition are therefore likely to influence receptor organisation and function, but how this precisely 
occurs is difficult to address given the intricacy of the PM lipid-network. Here, we combined biochemical 
assays and single molecule dynamic approaches to demonstrate that the local lipid environment regulates 
adhesion of integrin receptors by impacting on their lateral mobility. Induction of sphingomyelinase 
(SMase) activity reduced sphingomyelin (SM) levels by conversion to ceramide (Cer), resulting in impaired 
integrin adhesion and reduced integrin mobility. Dual-colour imaging of cortical actin in combination with 
single molecule tracking of integrins showed that this reduced mobility results from increased coupling to 
the actin cytoskeleton brought about by Cer formation. As such, our data emphasizes a critical role for the 
PM local lipid composition in regulating the lateral mobility of integrins and their ability to dynamically 
increase receptor density for efficient ligand binding in the process of cell adhesion.
In the modern view of the plasma membrane (PM), protein-protein, protein-lipid and lipid-lipid interactions occur 
in a dynamic fashion and lead to local segregation into PM compartments that are important to regulate signal 
transduction1,2. The best described PM compartments are the so called “lipid rafts” that are rich in cholesterol, 
glycosphingolipids, sphingomyelin (SM) and embed raftophilic proteins such as glycosylphosphatidyl-inositol 
anchored proteins (GPI-APs)2. Advances in microscopy techniques now allow direct visualisation of PM lipid nano-
domains, such as those consisting of the glycosphingolipids GM13, GM34, SM5 and PIP26. More recently, nanoscopy 
approaches have captured fast molecular movements of individual PM lipids in living cells revealing heterogeneous 
mobility behaviours including transient trapping of sphingolipids in cholesterol-mediated molecular complexes7–9.
The specific lipid nanoenvironment in which PM proteins are embedded seems crucial in regulating recep-
tor function. So is the activation state of an ion channel directly modified by its surrounding lipids10, and the 
allosteric transition of the epidermal growth factor receptor from an inactive to an active signalling dimer regu-
lated by interaction with GM311. Glycosphingolipids have also been implicated in providing membrane platforms 
facilitating to the formation of toxic amyloid-beta structures eventually leading to membrane fragmentation12,13. 
Similarly, cholesterol locally sequesters proteins involved in signal transduction14 or induces conformational 
changes of glycolipid headgroups, thereby modulating properties of bioactive glycolipids15. Also of interest is 
the role of cholesterol in modulating the selectivity of antimicrobial peptides for bacterial membranes, role that 
appears modulated by the localization of cholesterol into lipid rafts16–18.
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Strikingly, the cellular levels of (glyco)-sphingolipids and cholesterol as well as the expression of lipid metab-
olizing enzymes are altered in a variety of diseases including cancer19,20, in response to external stimuli such 
as pathogens21 or induced by drug treatment22. For example, modification of PM lipids by sphingomyelinase 
(SMase) is highly relevant in vivo, as triggering of human dendritic cells by Measle virus induces activation of 
SMase that locally alters the PM and further promotes virus uptake in these cells23. SMase induces breakdown 
of SM into Ceramide (Cer), which partially displaces cholesterol from rafts24,25 and leads to the formation of 
large Cer-enriched membrane domains in model membranes26,27. Importantly, formation and dynamics of 
Cer-enriched membrane platforms has been also documented in living cells28, where they can influence function 
and avidity state of several receptors21. For example, CD95 triggers apoptosis upon ceramide-induced cluster 
formation29 while ceramide platforms facilitate interactions between CD38 and the muscarinic type 1 (M(1)) 
receptor required for induction of intracellular cyclic ADP-ribose30 and locally promote the translocation of the 
transferrin receptor to clathrin-coated pits for subsequent endocytosis31. It is therefore plausible that the func-
tion and dynamics of many other transmembrane (TM) receptors are likely to be influenced by in vivo dynamic 
changes of lipid content in response to environmental cues.
Integrins are TM receptors that mediate cell-cell and cell-matrix interactions and play a key role during cell 
adhesion and migration. An α and a β subunit form a functional heterodimer, and their regulation occurs via 
conformational changes that alter affinity for their ligands32 or via dynamic redistribution within the membrane 
that locally increases the receptor density (i.e. valency) leading to increased avidity33. The hydrophobic TM 
regions of integrins have been recently shown to undergo important conformational changes that seem crucial 
in regulating integrin signalling34. These findings might challenge the classical protein-focused view on integrin 
regulation solely mediated by affinity and avidity mechanisms. Since the TM regions are in direct contact with the 
lipid nanoenvironment of the PM bilayer, it is very likely that changes in the local lipid composition can impact 
on integrin regulation. Indeed, an earlier study by Feldhaus and colleagues35 indicated that Cer generation by 
SMase impaired β 2 integrin-mediated adhesion, although the underlying molecular mechanisms for this inhibi-
tory effect remain so far unknown.
Lymphocyte function-associated antigen 1 (LFA-1, α Lβ 2) is a leukocyte specific integrin that mediates firm 
arrest on the endothelium and within the lymph nodes, cell tethering and the formation of the immunological 
synapse36. By exploiting high resolution imaging techniques, we showed that LFA-1 on quiescent monocytes is 
organized in well-defined nanoclusters37 that reside in nanoscale proximity to domains enriched in GPI-APs or 
GM1, without physical intermixing3,38. Importantly, we demonstrated an essential role of cholesterol in mediating 
LFA-1-GPI-AP interactions at the nanoscale and in the formation of larger raft-based adhesion sites upon ligand 
binding3,38. Furthermore, we applied single particle tracking (SPT) and showed that lateral diffusion and confor-
mation states of LFA-1 nanoclusters are highly interlinked: LFA-1 was mainly mobile, with slow and fast diffusion 
profiles, while a small sub-population of high-affinity LFA-1 was immobilized by anchorage to the cytoskeleton39. 
While several studies have reported a dependency of TM receptor mobility on the PM cholesterol, Cer and SM 
content40–42, it is still unknown whether these lipids contribute to the regulation of LFA-1 mobility and whether 
LFA-1 function is sensitive to changes in PM lipid composition.
In this study we investigated how the lipid nano-environment regulates LFA-1 function and mobility by reduc-
ing the SM content at the PM by myriocin or by conversion of SM into Cer by SMase. Our work demonstrates 
that SM conversion into Cer influences LFA-1 function and lateral mobility, suggesting the involvement of the 
cortical actin cytoskeleton. By combining SPT and biochemical assays, our results reveal that PM lipid alteration 
by induction of SMase activity can negatively affect integrin function by compromising lateral mobility, ultimately 
interfering with leukocyte adhesion.
Results
LFA-1 binding capacity and proximity to GM1 enriched domains are sensitive to the SM content 
in the plasma membrane. It has been previously shown that a decrease in SM levels on the PM negatively 
affected β 2 integrin activity in neutrophils35. Moreover, using super-resolution microscopy we demonstrated that 
LFA-1 binding to its ligand ICAM-1 on monocytes depended on cholesterol and its spatial proximity to GM1 and 
GPI-AP nanodomains3,38. These findings prompted us to investigate how local changes in other lipid raft compo-
nents, such as SM, would affect LFA-1 lateral organization and binding to ICAM-1. To understand how sensitive 
LFA-1 function is to local changes in SM, we determined the binding of monocytes to ICAM-1-Fc coated fluo-
rescent beads by flow cytometry after converting endogenous SM into Cer by recombinant SMase (Fig. 1A). In 
agreement with previous results37, around 40% of unperturbed monocytes spontaneously bound ICAM-1, and 
this interaction was specifically LFA-1 mediated, as shown by the effective blocking in the presence of an anti- α L 
mAb. In contrast, conversion of SM into Cer by SMase addition reduced the binding to ICAM-1 to less than 20%, 
as effectively as the blocking mAb. Of note, SMase was applied at optimal concentrations that preserved cell via-
bility, but significantly reduced the SM content at the membrane by efficiently inducing SM conversion into Cer, 
without affecting cholesterol or GM1 levels (Supplementary Fig. S1A–C). To note, SMase washout did not restore 
LFA-1 adhesion to ICAM-1 coated beads suggesting that the blocking effect of Cer formation remains for some 
time (Supplementary Fig. S1D), as also observed for other membrane receptors43.
To enquire whether the reduction in binding to ICAM-1 resulted from a decrease in LFA-1 cell surface expres-
sion and/or a change in LFA-1 affinity state in response to SMase treatment, we determined the binding of the α L 
specific neutral mAb TS2/4, the extension reporter antibody NKI-L1644, as well as the mAb L19 recognizing the 
integrin β 2 chain, before and after SMase treatment (Fig. 1B). Interestingly, we did not observe significant changes 
in expression levels of total LFA-1 or β 2 integrins with respect to unperturbed cells, neither changes in the expres-
sion levels of extended LFA-1. Altogether, these results indicate that SMase treatment impairs LFA-1-mediated 
adhesion in monocytes, without affecting LFA-1 cell surface expression levels or the degree of LFA-1 activation, 
as reported by the NKI-L16 Ab.
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Figure 1. LFA-1 binding capacity on monocytes and proximal distribution to GM1 is reduced by SMase.  
(A) Adhesion of human monocytes (THP-1) was determined using ICAM-1-Fc coated fluorescent beads at 
37 °C in unperturbed cells and upon treatment with SMase (0.05 U/ml). The % of adhesion represents the 
amount of cells that have bound beads as determined by flow cytometry. NKI-L15 mAb was used to block LFA-1. 
The data shows one representative experiment of 4 ± SD. (B) Relative expression of two α L–(TS2/4 and L16) 
and one β 2-(L19) specific epitope after treatment with SMase, assessed by flow cytometry. Left, representative 
FACS profiles in control cells and upon treatment with SMase. Right, changes in the mean fluorescent intensity 
are displayed as relative to control sample (expression levels in unperturbed cells were set as = 1, indicated by 
the dotted line). The data represent the mean ± SEM of 5–7 independent experiments. (C) Confocal microscopy 
analysis of co-capping of LFA-1 (L15 labeled) and GM1 (CTx-AF647) in untreated cells. (D) Confocal 
microscopy analysis of co-capping of LFA-1 (L15 labeled) and GM1 (CTx-AF647) in SMase treated cells. Images 
depict three representative cells for each condition. (E) Confocal microscopy analysis of co-capping of CD71 
and GM1 (CTx-AF647) in untreated cells. Receptor co-capping and staining were performed as described in 
Material and Methods. (F) Colocalization between LFA-1 or CD71 and GM1 as determined by the Manders 
coefficients (M1). Results are representative of multiple cells in three independent experiments. All P-values 
were compared to the respective unperturbed cells by 1way ANOVA with Student Neuman–Keuls post-test, 
***< 0.001.
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To investigate whether altered SM levels had an overall effect on the co-distribution of LFA-1 and the 
raft-associated GM1, we performed antibody-induced capping and confocal microscopy on untreated and SMase 
treated cells. On SMase treated cells, the co-distribution of LFA-1 and GM1 patches was visually reduced com-
pared to untreated cells (Fig. 1C,D). However, the integrity of LFA-1 nanoclusters remained unaffected by the 
treatment, as shown by Electron Microscopy images of whole-mount cells labelled for LFA-1 with 10 nm gold par-
ticles (Supplementary Fig. S2). The average Manders co-localization coefficient of the non-raft marker CD71 with 
GM1 (Fig. 1E) was 0.46, while raft-associated LFA-1 with GM1 in unperturbed cells showed a significantly higher 
co-localization coefficient of about 0.8 (Fig. 1F). In contrast, upon SMase treatment co-localization between 
LFA-1 and GM1 was significantly reduced (SMase = 0.68), suggesting an increasing exclusion of LFA-1 from 
GM1 enriched domains upon SM reduction and conversion to Cer. These results thus suggest that LFA-1 ligand 
binding and its association with raft components depend on the SM content in the PM of monocytes.
Conversion of SM into Cer alters LFA-1 lateral mobility. It has been extensively shown that the mobil-
ity of transmembrane receptors depends on the local PM environment41,42,45. Since SMase treatment decreased 
the overall content of SM with a concomitant increase of Cer production at the PM, we sought to investigate how 
changes in the lipid nano-environment as those induced by SMase affect LFA-1 lateral mobility. Individual LFA-1 
nanoclusters labeled with the neutral mAb TS2/4-Atto647N (sub-labeling conditions) were imaged in the ventral 
PM using a TIRF geometry (Fig. 2A) and individual trajectories were subsequently generated. Consistent with 
our previous results, LFA-1 trajectories in unperturbed monocytes showed diverse mobility, ranging from highly 
mobile to restricted and immobile (Fig. 2B)39. Treatment with SMase led to visually more restricted trajectories 
(Fig. 2B).
To quantify differences in the nanoscale diffusion behavior of LFA-1 nanoclusters, we analyzed individual 
trajectories by calculating the mean squared displacement (MSD) as a function of the time lag and generated his-
tograms of the short range diffusion coefficients (D1–4 values) (see methods) (Fig. 3A). In unperturbed monocytes 
the D1–4 values varied from 0.0046 μ m2/s (minimum detectable D1–4 value for mobile trajectories, see materials 
and methods section and supplementary Fig. S3) to 0.4 μ m2/s, with an average D1–4 = 0.04 ± 0.0001 μ m2/s and 
Figure 2. Trajectories of LFA-1 nanoclusters are visually affected by SMase. (A) Widefield image of a 
living THP-1 cell (left) and selected frame from a movie recorded at 100ms/frame in TIRF mode (middle). 
Bright spots correspond to individual LFA-1 nanoclusters labeled with TS2/4-Atto647N. Examples of different 
trajectories as they are tracked on the cell membrane of THP-1 cells over 200 frames (right). Scale bar: 10 μ m. 
(B) Representative trajectories of LFA-1 nanoclusters in unperturbed (left) and SMase (right) treated cells, 
illustrating different lateral mobilities.
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with ~22% of immobile nanoclusters (Fig. 3A,B). SMase treatment led to a shift of the D1–4 distribution to lower 
values with a two-fold decrease in the average D1–4 (0.024 ± 0.0002 μ m2/s), while the percentage of immobile 
nanoclusters was not significantly affected (Fig. 3A,B). To exclude the possibility that SMase treatment induced 
unwanted global changes in PM fluidity that could explain the reduction in LFA-1 mobility, we used fluorescence 
recovery after photobleaching to measure the mobility of the PKH dye, a lipid probe that inserts into the lipid 
bilayer. The results showed no difference in recovery of the PKH dye upon SMase treatment with respect to 
unperturbed cells (Supplementary Fig. S4), indicating no global fluidity changes on the PM that could explain the 
changes on LFA-1 mobility upon SMase treatment.
Since D1–4 only reports on the short-time diffusion behaviour, we performed cumulative probability distri-
bution (CPD) analysis on the ensemble of mobile trajectories to obtain information about the long-time (> 1 s) 
diffusion behavior of the mobile LFA-1 population (see Materials and Methods). Using this approach, we could 
discriminate a slow and a fast diffusing sub-population, and calculate their relative sizes (Fig. 3B). Notably, SMase 
treatment significantly increased the slow mobile sub-population from 26 ± 2% to 31 ± 2% and decreased the fast 
mobile sub-population from 53 ± 2% to 46 ± 2% (Fig. 3B).
The mobility was compared by plotting the CPD square displacement values against the respective time lags 
for the slow (Fig. 3C) and fast mobile (Fig. 3D) sub-populations in unperturbed and SMase-treated monocytes. 
The slow mobile sub-population was not significantly affected by the treatment (Fig. 3C and Table 1). In contrast, 
the square displacement plots of the fast mobile sub-population showed a remarkable reduction in the diffusion 
(from Df = 0.053 μ m2/s in unperturbed cells to Df = 0.035 μ m2/s in SMase treated cells) and an increase in the 
Figure 3. SMase influences the lateral mobility of LFA-1 nanoclusters. (A) Normalized semilog distribution 
of D1–4 values for LFA-1 nanoclusters in unperturbed control cells (grey) or after SMase (red) treatment. Each 
histogram contains at least 400 trajectories taken from > 30 cells in 5 experiments. The vertical dotted lines 
represent the average D1–4 values in control cells (black) and SMase treated cells (red). (B) Percentage of LFA-1 
nanocluster mobility classified as immobile, slow and fast mobile in unperturbed and SMase treated monocytes. 
The error bars represent the mean sub-population size ± SEM of 5 independent experiments. 2way ANOVA 
and Bonferroni post-test were applied to the full distribution of sub-population values calculated from at least 
30 cells in 3–5 experiments. P-values were compared to the respective unperturbed cells, *< 0.05, **< 0.01. 
(C,D) Square displacement plots of the slow (C) and fast (D) moving population of LFA-1 by fitting the CPD at 
different time lags (461–658 trajectories). Slow and fast diffusing components were fitted to a model of i) free 
(dashed lines) and ii) anomalous diffusion (continuous lines).
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anomalous diffusion (from α = 0.86 on unperturbed to α = 0.74 on SMase treated cells) in response to SMase 
treatment (Fig. 3D and Table 1).
To understand whether the observed effects of SMase on LFA-1 function and diffusion in monocytes are due 
to the formation of Cer or to a global reduction of the PM SM levels, we repeated the experiments after lowering 
the SM content by inhibition of the sphingolipid synthesis with myriocin46. Similar to SMase, myriocin reduced 
the binding to ICAM-1 with respect to unperturbed cells (Fig. 4A), without affecting the expression levels of total 
LFA-1 or β 2 integrins in general (Fig. 4B). Myriocin treatment did not affect cell viability (Supplementary Fig. S5), 
but significantly reduced the SM and GM1 content at the PM, with a similar trend for GPI-APs, without affecting 
cholesterol levels, in agreement with earlier findings47 (Fig. 4C). Moreover, myriocin reduced the co-localization 
of LFA-1 with GM1 from 0.78 to 0.63 in co-capping experiments (Supplementary Fig. S5), without affecting the 
integrity of LFA-1 nanoclusters (Supplementary Fig. S5).
Next we examined the effect of myriocin on the mobility of individual LFA-1 nanodclusters (Fig. 4D–G). 
Interestingly and in marked contrast to SMase, myriocin treatment did not significantly affect the D1–4 values of 
LFA-1 nanoclusters compared to untreated cells (Fig. 4D). Of note, myriocin is applied in the absence of serum 
(see Materials and Methods) and therefore the control condition represents serum-starved cells (see Table 2). 
Similarly, CPD analysis to characterize the long-term diffusion behaviour of LFA-1 nanoclusters showed no sig-
nificant differences in size (Fig. 4E) or the mobility of the slow and fast moving sub-populations of LFA-1 com-
pared to untreated cells (Fig. 4F,G and Table 2).
Since myriocin and SMase both reduce the SM content, but only SMase leads to formation of Cer, we conclude 
that Cer formation, rather than reduced SM levels, is responsible for slowing down of the fast sub-population of 
mobile LFA-1 nanoclusters, which also exhibited increased anomalous diffusion as indicated by the lower α value 
(Table 1). However, since these two drugs remove SM from the plasma membrane to a different extent, we can-
not exclude that SMase is simply much more powerful in depleting SM than myriocin thus explaining its higher 
impact on LFA-1 dynamics and function.
Cer formation also reduced the sub-population of fast mobile LFA-1 nanoclusters and increased the slow 
mobile sub-population (Table 1). These data collectively indicate that the metabolic reduction of SM and other 
glycosphingolipids by myriocin as well as the patho-physiological activation of SMase with subsequent conver-
sion of SM into Cer impact on LFA-1 function. The underlying molecular mechanisms are probably different, as 
Cer formation (but not myriocin) significantly hampers LFA-1 mobility.
Cer formation increases the association of LFA-1 with cortical actin. The extended form of LFA-1 
has been shown to interact with cortical actin39,48 and actin has also been implicated in cholesterol-based PM 
nanoheterogeneity49,50, suggesting that the propensity of LFA-1 to interact with the cortical cytoskeleton and its 
proximal distribution to GM1-enriched domains and GPI-APs3,38 are interrelated. Moreover, it has been reported 
that Cer formation interferes with the dynamic organisation of the actin cytoskeleton51. Since we observed a 
reduction in LFA-1 mobility upon Cer formation, and integrins are known to interact with the cytoskeleton, we 
sought to measure the mobility of individual LFA-1 nanoclusters after SMase treatment and subsequent addition 
of the actin polymerisation inhibitor Cytochalasin D (CytoD). First, we plotted the D1–4 values versus time-lag of 
unperturbed, SMase treated cells, as well as of cells treated with SMase and CytoD (Fig. 5A). Remarkably, addition 
of CytoD to SMase treated cells increased the average D1–4 from 0.024 ± 0.0003 μ m2/s to 0.039 ± 0.0004 μ m2/s, 
similar to the average diffusion values observed in unperturbed cells (0.040 ± 0.0001 μ m2/s, Fig. 5A).
CPD analysis revealed no significant change in the immobile sub-population of LFA-1 upon concomi-
tant addition of CytoD and SMase compared to SMase treated cells, however the slow sub-population slightly 
decreased from 31 ± 1.8% to 27 ± 2.5% and shifted towards the fast moving sub-population, which signifi-
cantly increased from 46 ± 1.9% to 51 ± 3.4% (Fig. 5B), suggesting that CytoD treatment reverses the changes in 
sub-population size observed upon SMase treatment closer to those observed in unperturbed cells.
Next, we plotted the CPD derived square displacement against the respective time lags for the slow and fast 
moving sub-populations of LFA-1 in unperturbed and SMase treated cells, and upon concomitant addition of 
CytoD and SMase (Fig. 5C,D). Addition of CytoD to SMase-treated cells strikingly released slow-diffusing LFA-1 
nanoclusters from constrains promoting their free diffusion on the cell surface (with α s going from 0.66 to 1.1) 
(Fig. 5C and Table 1). Moreover, actin disruption concomitant to Cer production almost completely abrogated 
the effects of SMase on the mobility of the fast LFA-1 population, with Df and α f values that became closer 
to those of fully unperturbed cells (Fig. 5D and Table 1). These results are interesting as they indicate that the 
slow population of LFA-1 nanoclusters is bound to the actin cytoskeleton and not affected by SMase treatment. 
Importantly, CytoD treatment reverses the diffusion behaviour of the fast LFA-1 population after SMase treat-
ment closer to untreated cells, strongly suggesting a cross-talk (or interactions) between actin and Cer influencing 
the mobility of fast LFA-1 nanoclusters.
N α slow
D[init] slow 
[μm2/s] α fast
D[init] fast 
[μm2/s] % immobile % slow % fast
Control 658 0.67 ± 0.05 0.0045 ± 4e-05 0.86 ± 0.01 0.053 ± 0.002 21.63 ± 2.37 25.86 ± 1.62 52.51 ± 2.24
SMase 461 0.66 ± 0.04 0.0051 ± 0.003 0.74 ± 0.02 0.035 ± 0.0009 22.06 ± 2.56 31.18 ± 1.83 45.75 ± 1.96
SMase + CytoD 262 1.1 ± 0.06 0.055 ± 7e-05 0.98 ± 0.02 0.049 ± 0.001 21.51 ± 2.04 27.26 ± 2.53 50.66 ± 3.46
Table 1.  Initial diffusion coefficients, α value and % of slow and fast sub-populations of LFA-1 
nanoclusters (imaged by mAb TS2/4 Atto647N) in unperturbed, SMase treated monocytes ± addition of 
CytoD.
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To investigate whether formation of Cer induces global changes in actin that could explain the slowing down 
of LFA-1, we imaged actin after SMase treatment by confocal and TIRF microscopy (Supplementary Fig. S6). 
Figure 4. Metabolic depletion of SM reduces LFA-1 adhesion without affecting its lateral mobility.  
(A) Monocyte adhesion to ICAM-1-Fc-coated fluorescent beads at 37 °C in unperturbed and myriocin-
treated cells. The % of adhesion represents the amount of cells that have bound beads as determined by flow 
cytometry. NKI-L15 mAb was used to block LFA-1. The data show one representative experiment of 4 ± SD. 
Differences were assessed by 1way ANOVA test, ***< 0.001. (B) Relative expression of α L– and β 2- specific 
epitopes were assessed by flow cytometry. Mean fluorescent intensity changes are displayed as relative to control 
sample (expression levels in unperturbed cells set as = 1, dotted line). The data represent the mean ± SEM of 
5–7 independent experiments. (C) Total SM content and PM cholesterol levels were determined by lysenin 
and filipin III labelling, respectively, while PM GM levels were detected by Ctx-AF647 and PM GPI-APs were 
detected by FLAER. The relative expression was assessed by flow cytometry and mean fluorescent intensity 
changes are relative to the respective unperturbed sample (expression levels in untreated cells set as = 1, dotted 
line). The data represent the mean ± SEM of 3–5 independent experiments. Differences were assessed by 1way 
ANOVA test, *< 0.05, ***< 0.001. (D) Normalized semilog distribution of D1–4 values for LFA-1 nanoclusters 
in unperturbed control (grey) or myriocin-treated cells (red). Vertical dotted lines represent the average D1–4 
values in control (black) and myriocin-treated cells (red). Each histogram contains at least 406 trajectories taken 
from 30 cells in 3–5 experiments. (E) Percentage of LFA-1 nanocluster mobility classified as immobile, slow and 
fast mobile in unperturbed and myriocin treated monocytes. The error bars represent the mean ± SEM of 3–5 
independent experiments. 2way ANOVA and Bonferroni post-test were applied to the full distribution of sub-
population values calculated from at least 30 cells in 3–5 experiments. (F,G) Square displacement plots of slow 
and fast moving LFA-1 populations by fitting the CPD at different time lags (461–658 trajectories). Slow and 
fast diffusing components were fitted to a model of i) free (dashed lines) and ii) anomalous (continuous lines) 
diffusion.
www.nature.com/scientificreports/
8Scientific RepoRts | 6:20693 | DOI: 10.1038/srep20693
While cell stretching was slightly reduced upon SMase treatment with respect to unperturbed cells, confocal and 
TIRF images did not show global changes in actin structure, labeled with Phalloidin, at the resolution limit of this 
approach. To determine whether nanoscale changes in the interaction of LFA-1 with cortical actin could occur 
after SMase treatment, we investigated the association of mobile LFA-1 nanoclusters with actin by simultaneous 
dual colour imaging of lifeact-GFP in combination with SPT of LFA-1 in TIRF mode. Trajectories of LFA-1 were 
overlaid on an image of the total actin signal in unperturbed cells as well as cells treated with SMase (Fig. 6A). 
N α slow
D[init] slow 
[μm2/s] α fast
D[init] fast 
[μm2/s] % immobile % slow % fast
Control (−serum) 467 0.93 ± 0.02 0.0039 ± 0.0002 0.9 ± 0.006 0.042 ± 0.0007 22.32 ± 2.70 20.97 ± 1.79 56.71 ± 2.56
Myriocin 406 0.79 ± 0.06 0.0032 ± 0.0005 0.86 ± 0.01 0.046 ± 0.002 24.58 ± 2.7 23.38 ± 1.98 52.04 ± 2.65
Table 2.  Initial diffusion coefficients, α value, and % of slow and fast sub-populations of LFA-1 
nanoclusters (imaged by mAb TS2/4 Atto647N) in unperturbed (cultured in the absence of serum) and 
myriocin treated monocytes.
Figure 5. Cer induced reduction and restriction of LFA-1 diffusion involves cortical actin. (A) Normalized 
semilog distribution of (D1–4) values for LFA-1 nanoclusters in control cells (top), upon SMase treatment 
without (middle) or with (bottom) addition of 5ug/ml CytoD during measurements. Each histogram contains 
at least 262 trajectories taken from 30 cells in 3 experiments. (B) Percentage of LFA-1 mobility classified as 
immobile, slow and fast mobile in control cells, SMase-treated cells without or with addition of 5ug/ml CytoD 
during measurement. The error bars represent the mean ± SEM of 5 independent experiments. 2way ANOVA 
and Bonferroni post-test were applied to the full distribution of sub-population values calculated from at least 
30 cells in 3–5 experiments, *< 0.05, **< 0.01. (C,D) CPD derived Square displacement plots of slow and fast 
moving LFA-1 nanoclusters in unperturbed cells (circle), SMase-treated cells without (square) or with addition 
of 5ug/ml CytoD (triangle) during measurement. Slow and fast diffusing components were fitted to a model of 
free and restricted/anomalous diffusion (see Table 1). The continuous line through the data points represents 
the fit of the anomalous diffusion model.
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To account for differences in the actin intensities amongst cells, we normalized the intensities on each image by 
assigning the highest intensity to 1 and the lowest to 0 (Fig. 6A). To quantify any potential correlation between 
the spatial location of the LFA-1 trajectories and the actin levels, we used a custom-written software to generate 
histograms of the normalized actin signal associated with each LFA-1 trajectory (Fig. 6B). Clearly, the distri-
bution of LFA-1 trajectories upon SMase treatment shifted from low towards intermediate actin signal values 
as compared to untreated cells (Fig. 6B). To substantiate these results we calculated the difference between the 
normalized frequency of localizations of LFA-1 trajectories from untreated and SMase treated cells at each value 
of the normalized actin signal (inset Fig. 6B). For actin signals between 0.5–0.6 the residuals are negative so that 
localizations of LFA-1 trajectories upon SMase treatment are dominant. Below and above 0.5–0.6 the residuals 
are positive and thus dominated by localisations of untreated LFA-1 trajectories (Fig. 6C). To account for the total 
percentage of localisations we separated the distributions in three subpopulations according to the actin signal 
Figure 6. Increased association of LFA-1 with the cytoskeleton upon Cer formation. (A) Dual colour 
images of lifeact-GFP transfected monocytes and SPT of LFA-1 nanoclusters (red trajectories) in control (left) 
and SMase (right) treated cells. After transfection with lifeact-GFP and, if applicable treatment with SMase, 
monocytes were labeled with TS2/4-Atto647N and seeded on fibronectin. Movies were recorded at 100ms/
frame in TIRF mode. Custom-written software was employed to quantify and normalize the actin signal in 
each cell by assigning the lowest actin intensity to 0 (blue) and the highest to 1 (yellow), as indicated in the 
color code (bottom). White dotted lines represent the cell boundaries. Within the control cell, selected area i) 
represents an example of a low actin signal, while selected area ii) is an example of a high actin signal in control 
cells, superimposed with the corresponding LFA-1 trajectories (red). Both selected areas are shown as enlarged 
images next to the control cell. (B) Distribution of the normalized actin intensity associated with each LFA-1 
trajectory in unperturbed (blue) or SMase treated cells (green). Each histogram contains at least 140 trajectories 
taken from 15 cells in multiple experiments. The data represents the mean ± SD obtained after bootstrapping of 
actin intensities measured in all experiments. The inset shows the difference between the normalized frequency 
of localizations of LFA-1 trajectories in unperturbed cells and upon SMase treatment as function of the 
normalized actin signal. P-values were compared to unperturbed cells by 2way ANOVA with Bonferroni post-
test, ***< 0.001. (C) Total percentages of LFA-1 trajectory localizations in unperturbed (blue) and SMase treated 
cells (green) associated with the normalized actin-GFP fluorescent signal for values < 0.4, 0.4–0.7 and > 0.7 as 
extracted from B.
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i.e. actin low (signals < 0.4), actin intermediate (signals 0.4–0.7) and actin rich (signals ≥ 0.7) regions (Fig. 6C). In 
unperturbed cells we found that ~36% of LFA-1 trajectories preferentially localised to actin-low areas (actin index 
0.1–0.4) and 46% to intermediate actin-intensities (0.4–0.6), and only a small fraction (~20%) colocalized with 
actin-rich areas (0.7–1) (Fig. 6C). In strong contrast, on SMase treated cells, a large percentage (80%) of LFA-1 
trajectories were found on intermediate actin intensities. These enriched actin regions would then increase the 
interaction of LFA-1 with the actin cytoskeleton hindering its mobility and explaining therefore the reduction of 
LFA-1 mobility and its increased anomalous diffusion after SMase treatment.
Discussion
In this study we investigated the effect of SM reduction on LFA-1 function, cell surface organisation and mobility 
in monocytes. By combining biochemical assays and extensive SPT and comparing the effect of the metabolic 
inhibitor myriocin with that of the membrane-associated enzyme SMase, we revealed that conversion of SM into 
Cer arrests LFA-1 nanocluster mobility and enhances the interactions of LFA-1 with cortical actin prior to ligand 
binding, thus providing an explanation for the impairment of LFA-1 adhesive function caused by SMase activity.
We have previously shown that on resting monocytes LFA-1 function is associated with the formation of 
LFA-1 nanoclusters that reside in nanoscale proximity to complexes enriched with raft components such as GM1 
and GPI-APs37,38. LFA-1 function and proximal distribution to raft domains were sensitive to changes in the 
lipid nano-environment induced by cholesterol depletion via methyl-β -cyclodextrin (MCD)38. Since MCD treat-
ment is known to induce global changes in membrane architecture and physiological processes such as signal-
ling52, we here used drugs that specifically reduced the SM content, the most common sphingolipid in eukaryotic 
membranes with an essential role in lipid nanodomain formation45. SMase converts SM into Cer by hydrolysis, 
while myriocin reduces the SM content by metabolic inhibition of the sphingolipid synthesis. In our experi-
ments, SMase or myriocin did not induce significant modifications of PM fluidity or impeded on cell surface 
availability of integrin receptors. Similar to MCD, SMase and myriocin reduced the proximity of LFA-1 towards 
GM1-enriched domains and impaired LFA-1 function, while the integrity of LFA-1 nanoclusters and the expres-
sion levels of LFA-1 were preserved. As both treatments reduced the SM levels, this suggests that the proximal 
distribution of LFA-1 to raft domains prior to ligand encounter3,38 is sensitive to SM levels. While SMase and 
myriocin both reduced the SM content of the PM, albeit to a different extent, the production of Cer by SMase 
induces additional molecular changes at the nanoscale, which affected integrin function and mobility differ-
ently from myriocin, strongly indicating that these treatments are not interchangeable. In addition, myriocin 
also affects the levels of GM1, whereas SMase does not. This could actually explain why myriocin inhibits LFA-1 
activity although it does not hamper integrin lateral dynamics. Our previous work demonstrated the existence of 
raft-based interconnectivity at the nanoscale between GPI-AP, LFA-1 and GM1 that forms the basis for large-scale 
raft coalescence upon cell activation3. SM and GM1 are both considered components of lipid rafts and reportedly 
occupy distinct domains within the PM5,53. However, GM1 has been shown to interfere with SM phase separation 
in model membranes54, suggesting mutual influence of these glycosphingolipids within the PM. Conversion of 
SM into Cer will most likely disturb the integrity of GM1 that, through the cholesterol-based connectivity among 
these domains, might in turn affect LFA-1. Myriocin might affect the nanoscale connectivity between LFA-1 and 
its PM neighboring partners that we know are important to strengthen nascent adhesion hotspots. Our findings 
once again strengthen the notion that SMase and myriocin induce different alterations to the PM, and that cau-
tion should be used when comparing results of these two conditions.
In contrast to myriocin, SMase lowers SM levels by conversion of SM into Cer, which strongly influences 
the global organisation and dynamical properties of the PM by the formation of larger Cer-enriched microdo-
mains21,24,25. In addition to the effects on LFA-1 function assigned to a reduction in SM content, the formation of 
Cer strongly impaired the mobility of LFA-1: SMase activation caused a relative increase of the LFA-1 slow mov-
ing sub-population, reduced mobility and increased restrictions on both slow and fast moving sub-populations 
most likely by increasing the interaction with actin. In addition, a reduction in mobility of LFA-1 by entrapment 
in Cer domains would decrease the likelihood of LFA-1 to diffuse to the ligand-binding site and to reinforce 
adhesion, consistent with a recent work showing that integrins cycle through phases of immobilization and dif-
fusion upon ligand binding in focal adhesions55. Whether LFA-1 nanoclusters are physically entrapped within 
Cer platforms needs to be investigated. Although addition of exogenous SM to SMase-treated cells would seem 
a logical step to rescue PM lipid content and monitor LFA-1 dynamics and function, there is ample evidence in 
the literature that exogenously added glycosphingolipids are mostly taken up by the cells with only a very minor 
part being re-inserted into the PM56–58. Fluorescently labelled lipids have been exogenously added to the cells to 
measure their lateral diffusion within the PM7,8. However, the aim of those experiments however was to obtain as 
sparse fluorescent lipids as possible within the plasma membrane to be able to perform single molecule measure-
ments by nanoscopy approaches such as STED or NSOM. Under these conditions, the massive internalization of 
the exogenously added lipids could be neglected as the studies focused on the few fluorescent lipids that managed 
to stay in the membrane.
Increased receptor clustering induced by Cer has been reported for PM receptors such as the co-stimulatory 
receptor CD4059 and apoptosis initiator CD9560, which is a prerequisite for receptor signalling. On the other 
hand, Cer formation has also been reported to hamper ligand binding capacity of the PM human serotonin1A 
receptor61 while increasing its lateral mobility62. Interestingly, in the case of LFA-1, Cer formation does not 
hamper LFA-1 mediated adhesion by interfering with the integrin nanoscale clustering but rather reduces and 
restricts LFA-1 diffusion eventually limiting the coalescence of several nanoclusters into stable ligand-binding 
areas. Future work will determine whether Cer leads to local rearrangements of the cortical actin that actively 
trap LFA-1 or whether there is a real inter-leaflet connection between Cer platforms and the actin cytoskeleton 
that overall will influence PM receptor mobility. Clearly, Cer formation affects PM receptors at different levels, 
and whether the effects are positive or negative for receptor function seems to depend on the type of receptor.
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The eukaryotic PM is connected to a dense actin-rich network (cortical actin) which regulates lipid-based 
PM nanoheterogeneity49,50 and hinders the diffusion of PM lipids in artificial membranes at physiological tem-
perature63. Our simultaneous SPT of LFA-1 and actin revealed increasing association of LFA-1 nanoclusters with 
cortical actin upon SMase treatment. Potentially, changes in the lipid nanoenvironment upon Cer production 
alter the interaction of LFA-1 with actin or actin binding proteins, such as Talin and Kindlin-364, which directly 
connect the cytoplasmic tails of integrins with the cytoskeleton. Interestingly, phospholipids of the inner PM were 
recently shown to directly influence the affinity of Talin-1 towards integrin β -chain and thereby regulating inte-
grin activation65, indicating that integrins are sensitive to changes in their surrounding lipid nanoenvironment. 
Recent elegant studies by Mayor and colleagues finally demonstrated the existence of PM transbilayer coupling 
that is important for nanoclustering of GPI-APs, providing the evidence that changes in the lipid content at the 
PM outer leaflet can be transduced to the inner leaflet66.
Several studies have indicated that Cer formation directly influences cortical actin remodeling by altering the 
cell biomechanical properties67, enhancing the assembly of complexes inducing actin polymerization68, decreas-
ing cell spreading capacity in measle virus infected T cells69 or directly interfering with the interactions between 
actin and the ERM proteins70,71. Future studies should address whether Cer formation has direct effect on the 
cortical actin in the monocytes, thus contributing to the altered interactions between LFA-1 and cortical actin 
observed here.
Our data are in line with previous findings showing that leukocyte adhesion on neutrophils was impaired 
upon Cer production, due to a defect of cytoskeletal organization and inside-out signaling35. Moreover, we now 
extend these findings by showing that impaired leukocyte adhesion is likely caused by altered interaction of LFA-1 
with the cytoskeleton and a reduction in LFA-1 mobility upon Cer production. Modification of adhesive prop-
erties or signaling cascades in immune cells by Cer is highly relevant under physiological conditions. Pathogens, 
such as measles virus, efficiently induce Cer domains in host T cells, which prevent b1-integrin mediated T cell 
motility by interference with actin dynamics51. Moreover, the sphingolipid and Cer content undergoes changes 
during cancer, inflammation and auto-immune diseases19. Our data indicate that such changes likely affect the 
adhesive properties of immune cells, which can ultimately impact on the immune response. Sphingolipid play 
an important role in cell adhesion as they regulate actin-binding proteins such as the ezrin, radixin, and moesin 
protein families70. A study on the effect of the chemotherapeutic cisplatin in cancer cell morphology has given 
mechanistic insights into the interplay between Cer and the cytoskeleton71. Activation of endogenous acid SMase 
by cisplatin increased the levels of Cer, which in turn activated the serine/threonine phosphatase PP2A that 
dephosphorylated the actin-binding protein ezrin. As a result, cortical actin dissociated from the PM resulting 
in the collapse of filopodia and consequently cell motility. LFA-1 adhesion strengthening implies the recruitment 
of actin-binding proteins to reinforce the ligand-binding site. Although not demonstrated yet, SMase-induced 
dephosphorylation of actin-binding proteins could contribute to reduced LFA-1 lateral mobility and adhesion by 
altering the association of the integrin with the cytoskeleton through a yet unknown mechanism.
In summary, this study provides evidence that LFA-1 mobility and function are sensitive to modification of 
the lipid nanoenvironment within the PM. Our data emphasizes a critical role for Cer in keeping the steady-state 
diffusion profile of LFA-1 which allows efficient ligand encounter by reinforcement of the binding site by mobile 
LFA-1 nanoclusters. A dynamically changing lipid content in response to metabolic changes during disease or in 
response to external stimuli72 might represent a so far unexplored mechanism to modulate cell adhesion in vivo, 
potentially exploited by cancer cells with altered adhesive properties, or by pathogens to modulate the adhesive 
properties of the host cell to escape immune surveillance .
Materials and Methods
Antibodies and Reagents. The mouse monoclonal antibodies (mAbs) against the integrin α L chain were 
NKI-L1573, NKI-L1637 and TS 2/4 (kindly provided by E. Martz), and the mouse mAb against the β 2 chain was 
L1973. For flow cytometry and SPT we included the mAb mouse anti-CD71 (clone B3/25). GM1 was labeled 
with recombinant Cholera Toxin Subunit B Alexa Fluor® 647-conjugated (Molecular Probes® ). To monitor cell 
viability we used AnnexinV-FITC (BD Pharmingen) and propidium iodide (SIGMA). GPI-APs were detected 
by fluorescently labeled aerolysin (FLAER) (Pinewood Scientific Services Inc.). Secondary stainings were per-
formed with Alexa 488–conjugated goat anti–mouse IgG2a and Alexa 647–conjugated goat anti–mouse IgG1 
(both Invitrogen). SM levels were reduced by addition of sphingomyelinase from Staphylococcus aureus (Merck, 
Calbiochem® ). For sphingolipid biosynthesis inhibition, myriocin from Mycelia sterilia (Sigma-Aldrich) was 
added during cell culture. Cytochalasin D was purchased from SIGMA. The mAb against LFA-1 (TS2/4) was 
labelled with Atto647N NHS ester (Fluka) at approximately 1:1 stoichiometry as determined by spectrophoto-
metric measurements (NanoDrop® ).
Cells and drug treatment. THP-1 monocytes were cultured in suspension in RPMI 1640 medium (Gibco) 
supplemented with 10% fetal calf serum (FCS, from Greiner), antibiotic-antimyotic (AA, from PAA) and ultra-
glutamine (UG, from Cambrex). One day prior to experiment, cell density was adjusted to a concentration of 
0.4 × 106/ml. For SPT studies, cells were cultured in phenol-red free RPMI 1640 medium (Gibco) supplemented 
with 10% FCS, AA and UG.
For SMase treatment, THP-1 cells were washed in serum-free RPMI 1640 medium and subsequently incu-
bated for 60 min at 37 °C in 0.05U/ml SMase, in the absence of serum. Control cells were treated in the same 
way except that SMase was not added. For sphingolipid biosynthesis inhibition, cells were cultured in complete 
medium (containing FCS, AA and UG) for 48 h in the presence of 10 μ M myriocin and then serum-starved for 14 
to 18 h in the presence of 10 μ M myriocin. Cytochalasin D was used at 5 μ g/ml and incubated for 5 min at 37 °C 
prior to measurements.
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Flow Cytometry. For flow cytometry analysis, cells were incubated (30 min, 4 °C) in PBS, 0.5% BSA, and 
0.01% sodium azide, with different mAbs (5 μ g/ml), followed by incubation with AF647-coupled goat anti-mouse 
IgG antibody (invitrogen) for 30 min at 4 °C. For GM1 labeling, cells were incubated with CtxAF647 for 20 min at 
4 °C. The relative fluorescence intensity was measured on a FACS-Calibur. Isotype-specific controls were included.
ICAM-1 Fc Fluorescent Bead Adhesion Assay. Carboxylate-modified streptavidin-coated 
TransFluorSpheres (488/645 nm, 1μ mØ; invitrogen) were coated with ICAM-1-Fc, and the bead adhesion 
assay was performed as described elsewhere 37. Briefly, the fluorescent beads were coated with biotinylated goat 
anti-human Fc antbodies and subsequently with ICAM-1-Fc chimera. This guarantees the outwards orientation 
of the ICAM-1 molecules with respect to the bead surface. After each coating step, several thorough washing 
steps ensure that the excess of unbound molecules is washed away. For the incubation, a ratio of 20 beads per 
cell was used. The blocking mAbs NKI-L15 was preincubated with the cells before adding the ligand-coated 
beads. Adhesion was determined as the percentage of cells that bound fluorescent beads by flow cytometry on a 
FACSCalibur (BD).
Confocal Microscopy. For co-capping experiments, THP-1 cells were stained at 4 °C with 5 μ g/ml anti–
LFA-1 mAb (clone NKI-L15 or TS2/4), anti-CD71 and Ctx-AF647. Isotype-specific controls were always 
included. Following extensive washing steps, patching was induced by incubation with the secondary antibody 
for 30 min at 4 °C, followed by 1 h incubation at 12 °C. Cells were extensively washed, fixed with 1% PFA and 
mounted onto poly-l-lysine–coated glass coverslips. Cells were imaged on an Olympus FV1000 Confocal Laser 
Scanning Microscope and signals were collected sequentially to avoid bleed through. Co-localization of LFA-1 
with GM1 was determined by calculating the Manders coefficients M1 (0 = no co-localization and 1 = 100% 
co-localization) using Image J (http://rsb.info.nih.gov/ij/,) plug-in JACoP74.
Labeling and sample preparation for single particle tracking using fluorescent 
dyes. Fc-receptors on THP-1 cells were blocked with 1% human serum (HS, from SIGMA) in medium for 
5 min at RT, followed by sub-labeling with non-blocking TS2/4-Atto647N in serum free/phenol-red free medium 
for 5 min at RT. As we were in particular interested to track LFA-1 nanoclusters instead of single LFA-1 heterod-
imers, we chose whole antibody over Fab fragments for tracking. Cells were extensively washed in serum-free/
phenol-red free medium. After washing, cells were seeded for 10 minutes at 37 °C on potassium hydroxide cleaned 
and sonicated Labtek II chambered cover-glasses (4 well, Nunc), coated with 20ug/ml fibronectin (Roche). 
Treatment with SMase or myriocin was performed prior to imaging and the drugs remained present for the time 
of the experiment. CytoD was added to the imaging medium and incubated for 5 min 37 °C prior to imaging.
Single molecule detection sensitive microscopy set-up. Fluorescence imaging of 
TS2/4-ATTO647N-labelled LFA-1 was performed on the ventral side of cells using an Olympus IX71 inverted 
microscope working in total internal reflection fluorescence (TIRF) geometry with a 150×, 1.45NA oil objective. 
Excitation of ATTO647N was provided by a 640-nm solid-state laser (power density at the focal plane < 1 kW/
cm2). Fluorescence was collected with the same objective and guided into an EM-CCD camera (Hamamatsu 
ImagEM) after suitable filtering. Movies were recorded at a frame rate of 10 Hz for a total of typically 200 frames. 
The sample temperature (34–36 °C) was maintained by a stage heater (Pecon) and an objective heater. Under our 
experimental conditions, the localization precision on the determination of the centroid positions of individual 
fluorescent spots resulted 25 nm, as assessed from measurements of individual TS2/4-ATTO647N on fixed cells 
(Fig. S4).
Fluorescence Trajectory Analysis. Two-dimensional trajectories of individual LFA-1 fluorescent spots 
in the focal plane were obtained using a custom-made single-particle tracking software (Bakker et al., 2012) 
Trajectories ≥ 13 frames were retained for analysis. Individual trajectories were analyzed by calculating the 
mean-square displacement (MSD) as a function of time lag (tlag). Short-range diffusion coefficients were extracted 
from the linear fit to the 1st–4th point of the MSD curve using the following equation MSD = 4D1–4tlag + Δ 0, where 
D1–4 is the short range diffusion coefficient and Δ 0 is the MSD offset at zero time increment. Histograms of all the 
D1–4 values per condition were then included in a semilog plot, showing the full distribution of diffusion values. 
The smallest detectable diffusion coefficient was obtained after imaging TS2/4-Atto647N on fixed cells using 
TIRFM at the same frame rate as in the corresponding experiments. The 95 percentile of the distribution of short 
range diffusion constants, which was 0.0046 μ m2/s for these spots on fixed cells, was considered as the minimum 
D1–4 value for mobile trajectories. In addition, we also generated cumulative MSD plots of all the mobile trajec-
tories per condition and performed linear fitting of the cumulative MSD plot through the first 1–4 points. From 
the fitting we extracted the average D1–4 value of the mobile population. Errors in the D values correspond to the 
standard deviation to the linear fitting.
Cumulative Probability Distribution (CPD) Analysis of mobile trajectories. To enquire on the 
long-term diffusion behavior (> 1.5 s) of mobile trajectories, we applied CPD analysis to the data using a similar 
approach as reported by Bakker et al. 2012. In short, mobile trajectories were first selected from the entire dataset 
as those displaying D1–4 > 0.0046 μ m2∕s. Then the CPD was created for the ensemble of the square displacements 
(r2) of these trajectories at different time lags and fitted with a two-population model describing random diffusion 
according to Schutz et al. 1997:
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where P (r2, t) is the probability that a particle starting at the origin will be found within a circle of radius r after 
time lag t. s is the normalized sub-population of slow LFA-1 nanoclusters, (1 −  s) the normalized sub-population 
of fast LFA-1 nanoclusters, rs the square displacement of the slow fraction at timelag t and rf the square displace-
ment of the fast fraction at timelag t. Then, slow and fast sub-population square displacement curves were fitted 
to derive average short range diffusion coefficient (D1–4) of each population was determined in a similar manner 
as described above for individual trajectories. In addition, the square displacement curves corresponding to the 
slow and fast diffusing populations were also fitted using the anomalous diffusion function (Bakker et al., 2012) 
to derive the anomalous parameter α for slow and fast LFA-1 populations, where α = 1 corresponds to free, 
Brownian diffusion and α < 1 corresponds to hindered, anomalous diffusion. Errors in the square displacements 
were estimated by bootstrapping (resampling residuals approach), the errors bars represent two times the stand-
ard deviation originated from fitting procedures.
Sample preparation for dual colour imaging and SPT experiments. For dual colour single molecule 
imaging of LFA-1 together with actin, THP-1 cells were transfected with lifeact-GFP by electroporation using 
the Neon® Transfection device (Invitrogen) and transfection materials (Invitrogen) according to manufactur-
er´s instructions. Briefly, 2 × 106 cells were transfected with a total of 5ug plasmid DNA. Electroporation was 
performed at 1300 V, 20 ms and 2 pulses. After electroporation, cells were plated in serum- and antibiotic -free 
medium for 3 hours at 37 °C. Subsequently, fetal calf serum and antibiotics were added to the medium and cells 
were cultured for 18 hours. Treatment with SMase was performed as described above.
Dual colour imaging was performed using a custom-built single molecule EPI/TIRF-fluorescence setup. 
Samples were illuminated in TIRF mode and excitation was provided by a He:Ne laser (633 nm, 4 ms, 1 kW/cm2) 
and an Ar + -Kr + laser (488 nm, 2 ms, ~2 kW/cm2). Fluorescence was collected with a 60 × 1.45 NA oil immer-
sion objective (Olympus PLAPO 60 × 0TIRFM NA1.45) and guided into an EM-CCD camera (Hamamatsu). 
Movies were collected at a frame rate of 10 Hz. Experiments were performed at 37 °C. Simultaneous two-color 
imaging was achieved by spectrally splitting the Atto647N (red) and lifeact-GFP (green) emissions onto different 
regions of the EM-CCD camera. Finally, a custom-designed image registration method was used to map the rel-
ative positions of the Atto647N and lifeact-GFP over the time course of data acquisition.
Statistics. The data were compared using 1way ANOVA and Student Neuman–Keuls post-test, or 2way 
ANOVA with Bonferroni post-test, as indicated. If not highlighted by an asterisk, the results were statistically not 
significant (ns).
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